A client taking methimazole reports anorexia, pruritus, and … | MyMerci
Adverse Effects/Contraindications/Interactions PPT
Question

A client taking methimazole reports anorexia, pruritus, and right-upper-quadrant pain. ALT and AST are more than 3 times the upper limit of normal. Which action is the priority?

Explanation
Compatible symptoms and transaminases above 3 times the upper limit require prompt discontinuation and evaluation under the methimazole label.
Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
Hold methimazole and escalate possible clinically significant hepatotoxicity.

Why this is correct
The label directs liver-function evaluation for anorexia, pruritus, or right-upper-quadrant pain and prompt discontinuation when clinically significant liver abnormality includes transaminases above 3 times normal.

Easy analogy or mental picture
When the organ-processing plant sounds an alarm, do not send another load through it.

Memory hook
Methimazole plus RUQ symptoms and marked enzymes: hold and evaluate.

NCLEX decision rule
Use symptom and laboratory thresholds together; do not normalize a trend that meets a labeled stop criterion.

Why the other choices are wrong
Food, dose escalation, and delayed review do not address the injury mechanism.
References
1DailyMed: MethimazoleAgranulocytosis warning and prompt discontinuation for clinically significant liver abnormality

Clinical scenario

Hepatic adverse-effect review
Assess symptoms, bilirubin, alkaline phosphatase, ALT, AST, current dose, and alternative causes before authorized rechallenge.
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.